Skip to content
Subscribe
Advertise
MDA.org
Donate
Subscribe
Donate
Menu
Magazine
Current Issue
Past Issues
Featured Content
Topics
Advocacy
Get Involved
Health
Inclusion
Independence
Lifestyle
News
Personal Stories
Science + Research
Diseases A-Z
Quest Blog
Podcast
Newsletter
News
Read the latest news about issues affecting the neuromuscular disease community.
Blog Post
MDA’s 2022 Advocacy Agenda
By
Mark Fisher
|
January 27, 2022
Blog Post
FDA Approves argenx’s Vyvgart for Treatment of gMG
By
Sujatha Gurunathan
|
December 20, 2021
Blog Post
Muscular Dystrophy Association Awards 18 Grants Totaling Over $1.6 Million for Neuromuscular Disease Research
By
Sujatha Gurunathan
|
November 5, 2021
Blog Post
It’s Open Enrollment Season. Here’s what you need to know!
By
Mark Fisher
|
November 1, 2021
Blog Post
Capricor Announces Positive Results from its Phase 2 Study of CAP-1002 to Treat DMD
By
Sujatha Gurunathan
|
September 30, 2021
Blog Post
Clinical Trial Alert: Phase 2 Study of Ifetroban in Individuals with DMD
By
MDA Staff
|
August 18, 2021
Blog Post
Clinical Trial Alert: Phase 2/3 and Open-Label Extension Study of ASP0367 in Individuals with Primary Mitochondrial Myopathy
By
MDA Staff
|
August 9, 2021
Blog Post
FDA Approves Sanofi Genzyme’s Nexviazyme for Treatment of Pompe Disease
By
MDA Staff
|
August 6, 2021
Blog Post
Research Study Alert: Survey for Caregivers of Children with SMA to Study Treatment Decision Making
By
MDA Staff
|
July 30, 2021
Blog Post
Clinical Trial Alert: Phase 1b/2a Study of Descartes-08 in Adults with Generalized Myasthenia Gravis
By
MDA Staff
|
July 30, 2021
« Previous
1
2
3
4
…
15
Next »
Skip to content
Open toolbar
Accessibility Tools
Increase Text
Decrease Text
Grayscale
High Contrast
Negative Contrast
Light Background
Links Underline
Readable Font
Reset